FDA inspection

Mark L. Brantly, M.D.: FDA inspection ending Apr 2, 2003

FDA inspection 269506 · Voluntary Action Indicated (VAI) · Gainesville, FL

Key facts

Inspection ID 269506
Firm Mark L. Brantly, M.D.
FEI number 3003556276
Address University of Florida School of Medicine, 1600 SW Archer Rd
City Gainesville
State FL
ZIP 32610-3003
Fiscal year 2003
Inspection end date Apr 2, 2003
Classification Voluntary Action Indicated (VAI)
Project area Blood & Blood Products
Product type Biologics

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections